Recombinant Mouse CCR2/CD192 Protein，His & Myc

CCR2 (C-C chemokine receptor type 2), also known as CD192, is a crucial receptor in the immune system that plays a significant role in the recruitment and migration of monocytes to sites of inflammation. This receptor is primarily expressed on monocytes, dendritic cells, and certain T cells, making it essential for processes such as tissue repair, inflammatory responses, and the development of various diseases, including autoimmune disorders and cancer. Given its pivotal role in mediating immune responses, CCR2 has emerged as a promising target for therapeutic interventions. Research into CCR2/CD192 recombinant proteins involves the development of these proteins for understanding their structure, function, and interactions with ligands. Such studies are critical for elucidating the mechanisms underlying CCR2 signaling pathways and their implications in health and disease. Additionally, recombinant CCR2 proteins can serve as valuable tools in both basic research and drug development, providing insights into receptor dynamics, potential inhibitors, and the design of more effective therapeutic strategies aimed at modulating immune responses. This growing body of research underscores the potential of CCR2/CD192 as a focal point for new treatments in inflammatory diseases, thus contributing to the advancement of precision medicine in immunology.